[Experience in treating peripheral T-cell lymphomas by a new program]

To treat patients with an accurately verified peripheral T-cellular lymphoma presenting with a high degree malignancy, there has been used a new aggressive chemotherapeutic protocol "Bu". It is more effective than the well known protocol CHOP. 83% patients achieved complete remission as well as long-term survival. Immunophenotyping of cells of malignant lymphomas had been done before choosing the relevant chemotherapeutic treatment policy.